Cargando…

Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients

Currently, amrubicin is permitted for relapsed small-cell lung carcinoma (SCLC) only in Japan. The efficacy and adverse effects of amrubicin as reported by previous studies varied greatly. The inclusion criterion was a prospective study that was able to provide data for efficacy and safety by the AM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horita, Nobuyuki, Yamamoto, Masaki, Sato, Takashi, Tsukahara, Toshinori, Nagakura, Hideyuki, Tashiro, Ken, Shibata, Yuji, Watanabe, Hiroki, Nagai, Kenjiro, Nakashima, Kentaro, Ushio, Ryota, Ikeda, Misako, Kobayashi, Nobuaki, Shinkai, Masaharu, Kudo, Makoto, Kaneko, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707435/ https://www.ncbi.nlm.nih.gov/pubmed/26750506 http://dx.doi.org/10.1038/srep18999

Ejemplares similares

Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary Tuberculosis
por: Tsukahara, Toshinori, et al.
Publicado: (2017)

Sensitivity and specificity of Cobas TaqMan MTB real-time polymerase chain reaction for culture-proven Mycobacterium tuberculosis: meta-analysis of 26999 specimens from 17 Studies
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Diagnostic test accuracy of loop-mediated isothermal amplification assay for Mycobacterium tuberculosis: systematic review and meta-analysis
por: Nagai, Kenjiro, et al.
Publicado: (2016)

Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis
por: Shibata, Yuji, et al.
Publicado: (2016)

HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients
por: Tashiro, Ken, et al.
Publicado: (2017)

The Platelet Count Can Predict In-hospital Death in HIV-negative Smear-positive Pulmonary Tuberculosis Inpatients
por: Goto, Hideto, et al.
Publicado: (2018)

Age, Dehydration, Respiratory Failure, Orientation Disturbance, and Blood Pressure Score Predicts In-hospital Mortality in HIV-negative Non-multidrug-resistant Smear-positive Pulmonary Tuberculosis in Japan
por: Nagai, Kenjiro, et al.
Publicado: (2016)

Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis
por: Chen, Hao, et al.
Publicado: (2020)

Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study
por: Fujii, Hiroaki, et al.
Publicado: (2022)

Oktett, D. 803
por: Schubert, Franz, 1797-1828
Publicado: (1988)

Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma
por: Sakaida, Emiko, et al.
Publicado: (2017)

Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited‐disease small cell lung cancer
por: Sekine, Ikuo, et al.
Publicado: (2016)

The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis
por: Horita, Nobuyuki, et al.
Publicado: (2017)

Schedule of experiment R803
por: Jarlskog, G
Publicado: (1973)

Oktett F-Dur, D. 803= octet in F major D 803
por: Schubert, Franz 1797-1828
Publicado: (2014)

Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial
por: Kobayashi, Nobuaki, et al.
Publicado: (2020)

ELISA Development for Serum Hemeoxygenase-1 and Its Application to Patients with Acute Respiratory Distress Syndrome
por: Hara, Yu, et al.
Publicado: (2018)

Incremental low doses of amrubicin for the treatment of bone marrow metastasis in small cell lung cancer
por: Asai, Nobuhiro, et al.
Publicado: (2013)

Octets D. 803 , D. 72
por: Schubert, Franz, 1797-1828
Publicado: (1993)

Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer
por: Chen, Hao, et al.
Publicado: (2020)

Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia
por: Murohashi, Kota, et al.
Publicado: (2018)

Regulatory role of heme oxygenase-1 in silica-induced lung injury
por: Nakashima, Kentaro, et al.
Publicado: (2018)

Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
por: Ando, Takayuki, et al.
Publicado: (2015)

Tumor‐selective Distribution of an Active Metabolite of the 9‐Aminoanthracycline Amrubicin
por: Noguchi, Toshihiro, et al.
Publicado: (1998)

Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
por: Ikeda, Takaya, et al.
Publicado: (2020)

Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax
por: Aoki, Ayako, et al.
Publicado: (2020)

R803 at intersection I8, ISR
Publicado: (1975)

R803 at intersection I8, ISR
por: CERN PhotoLab
Publicado: (1975)

R803 at intersection I8, ISR
por: CERN PhotoLab
Publicado: (1975)

Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
por: Kimura, Tatsuo, et al.
Publicado: (2011)

Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots
por: Imamura, Fumio, et al.
Publicado: (2015)

In vivo Efficacy and Tumor‐selective Metabolism of Amrubicin to Its Active Metabolite
por: Noguchi, Toshihiro, et al.
Publicado: (1998)

The clinical significance of CXCL16 in the treatment of advanced non‐small cell lung cancer
por: Shibata, Yuji, et al.
Publicado: (2020)

Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study
por: Akamatsu, Hiroaki, et al.
Publicado: (2021)

803. Overcoming β-Lactam Resistance in Mycobacterium abscessus
por: Story-Roller, Elizabeth, et al.
Publicado: (2018)

IL-15 and N-803 for HIV Cure Approaches
por: Howard, J. Natalie, et al.
Publicado: (2023)

Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials
por: Matsumoto, Hiromi, et al.
Publicado: (2021)

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
por: Nishimura, Tadashi, et al.
Publicado: (2022)

Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin
por: Yamamoto, Michiko, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kd6n0puqkh4157vvm62ee9mn38